An emulsion formulation of amphotericin b improves the therapeutic index when treating systemic murine candidiasis

Journal of Infectious Diseases

Volumn 158, Issue 5, 1988, Pages 1065-1070

  Kirsh, R ^a   Goldstein, R ^a   Tarloff, J ^a   Parris, D ^a   Hook, J ^a   Hanna, N ^a   Bugelski, P ^a   Poste, G ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; POTASSIUM;

ANIMAL EXPERIMENT; CANDIDA ALBICANS; CANDIDIASIS; FUNGUS; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANIMAL; CANDIDIASIS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; COMPARATIVE STUDY; EMULSIONS; ERYTHROCYTES; HUMAN; LIPOSOMES; MALE; MICE; POTASSIUM; RATS; RATS, INBRED STRAINS;

EID: 0023743895     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/158.5.1065     Document Type: Article

References (23)

1. Singer C, Kaplan MH, Armstrong D. Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med 1977;62:731-42
2. Bodey GP. Infectious complications in the cancer patient. Curr Probl Cancer 1977;1:1-63
3. Verhoeff J, Peterson PK, Quie PG, eds. Infections in the immunocompromised host -Pathogenesis, prevention and therapy, Amsterdam: Elsevier, North-Holland 1980
4. Cho SY, Choi HY. Opportunistic fungal infection among cancer patents. A ten-year autopsy study. Am J Clin Pathol 1979;72:617-21
5. Krick JA, Remington JS. Opportunistic invasive fungal infections in patients with leukaemia and lymphoma. Clin Lab Haematol 1976;5:249-310
6. Mirsky HS, Cuttner J. Fungal infection in acute leukemia. Cancer 1972;30:348-52
7. Rosen PP. Opportunistic fungal infections in patients with neoplastic diseases. Pathol Annu 1976;11:255-315
8. Bodey GP, Rodriguez V, Chang H-Y, Narboni G. Fever and infection in leukemic patients. A study of 494 consecutive patients. Cancer 1978;41:1610-22
9. Bodey GP. Fungal infections complicating acute leukemia. J Chronic Dis 1966;19:667-87
10. Winston DJ, Gale RP, Meyer DV, Young LS. Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 1979;58:1-31
11. Fungizone® intravenous physicians’ desk reference, ER Barnhart, ed. 39th ed. Oradell, NJ: Medical Economics, 1985;1994-6
12. De Kruijff B, Demel RA. Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. III. Molecular structure of the polyene antibiotic-cholesterol complexes. Biochim Biophys Acta 1974;339:57-70
13. Graybill JR, Craven PC, Taylor RL, Williams DM, Magee WE. Treatment of murine cryptococcosis with liposome-associated amphotericin. J Infect Dis 1982;145:748-52
14. Tkylor RL, Williams DM, Craven PC, Graybill JR, Drutz DJ, Magee WE. Amphotericin B in liposomes: A novel therapy for histoplasmosis. Am Rev Respir Dis 1982;125:610-11
15. Lopez-Berestein G, Mehta R, Hopfer RL, Mills K, Kasi L, Mehta K, Fainstein V, Luna M, Hersh EM, Juliano R. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin. J Infect Dis 1983;147:939-45
16. Tremblay C, Barza M, Fiore C, Szoka F. Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob Agents Chemother 1984;26:170-3
17. Lopez-Berestein G, Fainstein V, Hopfer R, Mehta K, Sullivan MP, Keating M, Rosenblum MG, Mehta R, Luna M, Hersh EM, Reuben J, Juliano RL, Bodey GP. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study. J Infect Dis 1985;151:704-10
18. Mehta R, Lopez-Berestein G, Hopfer R, Mills K, Juliano RL. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim Biophys Acta 1984;770:230-4
19. Lopez-Berestein G, Rosenblum MG, Mehta R. Altered tissue distribution of amphotericin B by liposomal encapsulation: Comparison of normal mice to mice infected with Candida albicans. Cancer Drug Deliv 1984;1:199-205
20. Margosis M, Aszalos A. Quantitation of Amphotericins by reverse-phase high-performance liquid chromatography. J Pharm Sci 1984;73:835-8
21. Kotler-Brajtburg J, Price HD, Medoff G, Schlessinger D, Kobayashi GS. Molecular basis for the selective toxicity of amphotericin B for yeast and filipin for animal cells. Antimicrob Agents Chemother 1974;5:377-82
22. Kotler-Brajtburg J, Medoff G, Kobayashi GS, Schlessinger D, Atallah A. Sensitivity to amphotericin B and the cholesterol: Phospholipid molar ratios of 3T3, L, BHK and HeLa cells. Biochem Pharmacol 1977;26:705-10
23. Poste G, Kirsh R, Koestler T. The challenge of liposome targeting in vivo. In: Gregoriadis G, ed. Liposome technology, Vol. 3. Targeted Drug delivery and biological interaction. Boca Raton, Fla: CRC Press, 1984:1-28